STRATA Skin Sciences Files 8-K

TL;DR

STRATA Skin Sciences filed an 8-K on Nov 11, 2024, with financial updates.

AI Summary

STRATA Skin Sciences, Inc. filed an 8-K on November 11, 2024, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as MELA SCIENCES, INC. and ELECTRO OPTICAL SCIENCES INC, is incorporated in Delaware and headquartered in Horsham, Pennsylvania.

Why It Matters

This filing indicates updates regarding the company's disclosures and financial reporting, which are important for investors to stay informed about the company's status.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, typically for disclosures and exhibits, without immediate indication of significant negative events.

Key Players & Entities

• STRATA Skin Sciences, Inc. (company) — Registrant
• MELA SCIENCES, INC. (company) — Former Company Name
• ELECTRO OPTICAL SCIENCES INC (company) — Former Company Name
• November 11, 2024 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of Incorporation
• Horsham, Pennsylvania (location) — Principal Executive Offices

FAQ

Key Financial Figures

• $0.001 — ange on which registered Common Stock, $0.001 par value per share SSKN The NASDAQ

Filing Documents

• ef20038369_8k.htm (8-K) — 28KB
• ef20038369_ex99-1.htm (EX-99.1) — 13KB
• image00001.jpg (GRAPHIC) — 3KB
• 0001140361-24-045945.txt ( ) — 187KB
• sskn-20241111.xsd (EX-101.SCH) — 4KB
• sskn-20241111_lab.xml (EX-101.LAB) — 21KB
• sskn-20241111_pre.xml (EX-101.PRE) — 16KB
• ef20038369_8k_htm.xml (XML) — 4KB

01

Item 7.01. Regulation FD Disclosure. On November 11, 2024, STRATA Skin Sciences, Inc. (the "Company" or "STRATA") issued a press release announcing that the United States District Court for the Eastern District of Pennsylvania entered a court order in favor of the Company in its complaint against LaserOptek America Corp. ("LaserOptek"), Monarch Aesthetic Services, Inc. d/b/a Monarch Laser Services ("MLS"), and The Pinnacle Health Group ("Pinnacle"), collectively referred to as the "Defendants. Among other things, the court order bars LaserOptek and other parties acting at its direction from engaging in any sales, advertising, marketing or promotion of Pallas lasers that states or implies, directly or indirectly, that treatments with Pallas laser systems are reimbursable using CPT Codes 96920-96922, and further enjoins those parties from engaging in any sales, advertising, marketing or promotion of Pallas lasers in the United States that includes any false or misleading statements regarding the Pallas lasers or STRATA's lasers. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information set forth in this item 7.01, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act or otherwise subject to the liabilities of such section, nor shall such information be deemed incorporated by reference in any filing under the Securities Act or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

Financial Statements and Exhibits

Financial Statements and Exhibits. (d) Exhibits. The following press release is furnished as an exhibit to this Current Report on Form 8-K and shall not be deemed to be "filed": Exhibit No. Exhibit Description 99.1 Press release dated November 11, 2024, issued by Strata Skin Sciences, Inc. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STRATA SKIN SCIENCES, INC. Date: November 12, 2024 By: Dolev Rafaeli Dr. Dolev Rafaeli Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR